Automation index

How much of a Pharmacovigilance officer’s job can AI already do?

An ADR case comes earlier. Calling it serious without staying quiet to the regulator do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#186 / 643

Pharmacovigilance officer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Case, the file and MedDRA. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Seriousness, the link and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
File, the AEMPS deadline and not delaying. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Signal, the aggregate and not playing it down. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The doctor, the ADR and not arguing the story. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
If it is serious, call it. And not staying quiet. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low